Mark A Espeland1, Stephen R Rapp2, George A Bray3, Denise K Houston4, Karen C Johnson5, Abbas E Kitabchi6, Andrea L Hergenroeder7, Jeff Williamson8, John M Jakicic9, Brent van Dorsten10, Stephen B Kritchevsky4. 1. Department of Biostatistical Sciences and mespelan@wakehealth.edu. 2. Department of Psychiatry and Behavioral Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina. 3. Pennington Biomedical Research Center, Louisiana State University, Baton Rouge. 4. Section on Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina. 5. Department of Preventive Medicine and. 6. Department of Medicine, University of Tennessee Health Science Center, Memphis. 7. Department of Physical Therapy, University of Pittsburgh, Pennsylvania. 8. Section on Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina. Kulynych Center for Memory and Cognition Research, Wake Forest School of Medicine, Winston-Salem, North Carolina. 9. Department of Health and Physical Activity, University of Pittsburgh, Pennsylvania. 10. Colorado Center for Behavioral Medicine, Denver.
Abstract
BACKGROUND: It is unknown whether intentional weight loss provides long-term benefits for cognitive function. METHODS: An ancillary study to a randomized controlled clinical trial was conducted in overweight and obese individuals (N = 978), aged 45-76 years at enrollment, with type 2 diabetes. An intensive behavioral intervention designed to promote and maintain weight loss through caloric restriction and increased physical activity was compared with diabetes support and education. Standardized assessments of cognitive function were collected an average of 8.1 years after trial enrollment. RESULTS: Participants assigned to intensive lifestyle intervention lost a mean (SE) 11.1% (0.4%) and 7.2% (0.5%) of weight at Years 1 and 8, respectively, compared with 1.0% (0.2%) and 3.3% (0.5%) in the control group (p < .001). Covariate-adjusted mean composite cognitive function test scores were similar for the two groups (p = .69), and no significant differences were found for any individual cognitive test. There was some evidence of a differential effect (nominal interaction p = .008) for a prespecified comparison: Intensive lifestyle intervention was associated with a relative mean benefit for composite cognitive function of 0.276 (95% confidence interval: 0.033, 0.520) SDs among individuals with body mass index less than 30 kg/m(2) at baseline compared with a relative mean deficit of 0.086 (-0.021, 0.194) SDs among individuals with body mass more than or equal to 30 kg/m(2). CONCLUSIONS: Eight years of intensive lifestyle intervention did not alter cognitive function in obese adults with type 2 diabetes; however, there was evidence for benefit among overweight but not obese individuals. Changes in cognition were not assessed in this cross-sectional study.
RCT Entities:
BACKGROUND: It is unknown whether intentional weight loss provides long-term benefits for cognitive function. METHODS: An ancillary study to a randomized controlled clinical trial was conducted in overweight and obese individuals (N = 978), aged 45-76 years at enrollment, with type 2 diabetes. An intensive behavioral intervention designed to promote and maintain weight loss through caloric restriction and increased physical activity was compared with diabetes support and education. Standardized assessments of cognitive function were collected an average of 8.1 years after trial enrollment. RESULTS:Participants assigned to intensive lifestyle intervention lost a mean (SE) 11.1% (0.4%) and 7.2% (0.5%) of weight at Years 1 and 8, respectively, compared with 1.0% (0.2%) and 3.3% (0.5%) in the control group (p < .001). Covariate-adjusted mean composite cognitive function test scores were similar for the two groups (p = .69), and no significant differences were found for any individual cognitive test. There was some evidence of a differential effect (nominal interaction p = .008) for a prespecified comparison: Intensive lifestyle intervention was associated with a relative mean benefit for composite cognitive function of 0.276 (95% confidence interval: 0.033, 0.520) SDs among individuals with body mass index less than 30 kg/m(2) at baseline compared with a relative mean deficit of 0.086 (-0.021, 0.194) SDs among individuals with body mass more than or equal to 30 kg/m(2). CONCLUSIONS: Eight years of intensive lifestyle intervention did not alter cognitive function in obese adults with type 2 diabetes; however, there was evidence for benefit among overweight but not obese individuals. Changes in cognition were not assessed in this cross-sectional study.
Authors: Jennifer Weuve; Eric J Tchetgen Tchetgen; M Maria Glymour; Todd L Beck; Neelum T Aggarwal; Robert S Wilson; Denis A Evans; Carlos F Mendes de Leon Journal: Epidemiology Date: 2012-01 Impact factor: 4.822
Authors: Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski Journal: N Engl J Med Date: 2013-06-24 Impact factor: 91.245
Authors: Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski Journal: Control Clin Trials Date: 2003-10
Authors: Gary D Foster; Kelley E Borradaile; Mark H Sanders; Richard Millman; Gary Zammit; Anne B Newman; Thomas A Wadden; David Kelley; Rena R Wing; F Xavier Pi-Sunyer; David Reboussin; Samuel T Kuna Journal: Arch Intern Med Date: 2009-09-28
Authors: Mark A Espeland; Owen Carmichael; Kathleen Hayden; Rebecca H Neiberg; Anne B Newman; Jeffery N Keller; Thomas A Wadden; Stephen R Rapp; James O Hill; Edward S Horton; Karen C Johnson; Lynne Wagenknecht; Rena R Wing Journal: J Gerontol A Biol Sci Med Sci Date: 2018-03-14 Impact factor: 6.053
Authors: Stephen R Rapp; Jose A Luchsinger; Laura D Baker; George L Blackburn; Helen P Hazuda; Kathryn E Demos-McDermott; Robert W Jeffery; Jeffrey N Keller; Jeanne M McCaffery; Nicholas M Pajewski; Mary Evans; Thomas A Wadden; Steven E Arnold; Mark A Espeland Journal: J Am Geriatr Soc Date: 2017-01-09 Impact factor: 5.562
Authors: Priya Palta; A Richey Sharrett; Jennifer A Deal; Kelly R Evenson; Kelley Pettee Gabriel; Aaron R Folsom; Alden L Gross; B Gwen Windham; David Knopman; Thomas H Mosley; Gerardo Heiss Journal: Alzheimers Dement Date: 2018-10-12 Impact factor: 21.566
Authors: Kristen M Beavers; Iris Leng; Stephen R Rapp; Michael E Miller; Denise K Houston; Anthony P Marsh; Don G Hire; Laura D Baker; George A Bray; George L Blackburn; Andrea L Hergenroeder; John M Jakicic; Karen C Johnson; Mary T Korytkowski; Brent Van Dorsten; Stephen B Kritchevsky Journal: J Am Geriatr Soc Date: 2016-09-27 Impact factor: 5.562
Authors: Kaycee M Sink; Mark A Espeland; Cynthia M Castro; Timothy Church; Ron Cohen; John A Dodson; Jack Guralnik; Hugh C Hendrie; Janine Jennings; Jeffery Katula; Oscar L Lopez; Mary M McDermott; Marco Pahor; Kieran F Reid; Julia Rushing; Joe Verghese; Stephen Rapp; Jeff D Williamson Journal: JAMA Date: 2015-08-25 Impact factor: 56.272
Authors: Ramon Casanova; Satoru Hayasaka; Santiago Saldana; Nick R Bryan; Kathryn E Demos; Lisa Desiderio; Kirk I Erickson; Mark A Espeland; Ilya M Nasrallah; Thomas Wadden; Paul J Laurienti Journal: Psychoneuroendocrinology Date: 2016-09-23 Impact factor: 4.905
Authors: Ping Zhang; Don Hire; Mark A Espeland; William C Knowler; Sheikilya Thomas; Adam G Tsai; Henry A Glick Journal: Obesity (Silver Spring) Date: 2016-03-08 Impact factor: 5.002
Authors: J Lehtisalo; J Lindström; T Ngandu; M Kivipelto; S Ahtiluoto; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; J G Eriksson; M Uusitupa; J Tuomilehto; J Luchsinger Journal: J Nutr Health Aging Date: 2016-02 Impact factor: 4.075